Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2021-10-18 Capital/Financing Update
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
Proposed issue of securities - LCT 5 pages 28.1KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Living Cell Technologies Limited. It details the number of securities to be issued, the issue price, the proposed issue date, and other related information such as fees and the purpose of the issue. The document references ASX Listing Rules and placement capacities but does not contain financial statements or detailed financial performance data. It is a regulatory announcement about capital raising activities, specifically a placement of shares. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or other categories.
2021-10-18 English
Cleansing Notice 2 pages 448.3KB
Capital/Financing Update Classification · 95% confidence The document is a notice titled 'Cleansing notice under Section 708AA(2)(f) of the Corporations Act 2001 (Cth)' dated 19 October 2021. It announces an equity raise by way of Placement to sophisticated and wholesale investors, specifying the amount raised and the number of shares issued. The notice references compliance with the Corporations Act and ASX Listing Rules, and provides details about the placement shares and the company's status. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is a formal announcement related to capital raising activity, specifically a placement of shares, rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (5762 characters) supports it being a full notice rather than a brief announcement of a report publication. Confidence is high given the clear focus on equity raise and placement details.
2021-10-18 English
Pause in Trading 1 page 112.1KB
Regulatory Filings Classification · 95% confidence The document is a brief market release announcing a temporary pause in trading of the company's securities. It is very short (360 characters) and does not contain any financial data, report content, or detailed information. It is an official regulatory announcement related to trading status, which fits best under Regulatory Filings (RNS) as a general regulatory announcement. It is not a financial report, management update, or other specific filing type.
2021-10-14 English
Trading Halt 4 pages 535.2KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Living Cell Technologies Limited regarding a trading halt requested pending an announcement related to an equity raising via institutional placement and pro rata offer. It is dated 15 October 2021 and is issued by the company secretary. The content is focused on the trading halt request and does not contain any financial statements, detailed financial data, or report content. It is a regulatory announcement about a trading halt, which is a typical regulatory filing to inform the market and comply with ASX Listing Rules. The document length is 6148 characters, but the content is clearly an announcement rather than a full report or financial disclosure. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-10-14 English
2021 Annual General Meeting 20 pages 1.5MB
AGM Information Classification · 100% confidence The document is an ASX announcement from Living Cell Technologies Limited regarding their 2021 Annual General Meeting (AGM). It includes details about the meeting date, time, virtual attendance instructions, proxy voting procedures, and references to the Notice of Meeting and other meeting materials. The document does not contain the actual financial report or detailed financial statements but rather the meeting logistics and related shareholder information. It explicitly states that the Notice of Meeting and other materials are attached or available online, indicating this is an announcement about the AGM and its materials rather than the materials themselves. Therefore, this document fits the category of AGM Information (AGM-R).
2021-10-07 English
Annual Report to shareholders 44 pages 8.6MB
Annual Report Classification · 100% confidence The document is titled '2020 - 2021 ANNUAL REPORT' and contains detailed sections typical of an annual report, including an Executive Chairman's letter, Directors' report, Auditor's independence declaration, consolidated financial statements (profit or loss, financial position, changes in equity, cash flows), notes to the financial statements, Directors' declaration, and Independent auditor's report. The content covers the full fiscal year ended 30 June 2021, with comprehensive financial and corporate information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. There is no indication that this is merely a report publication announcement or a certification document. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2021-10-07 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.